skip to main content
Investor Relations

Investor Relations

Press Releases

September 1, 2014
GE Healthcare Announces European Union Approval of VIZAMYL™ (Flutemetamol (18F) solution for injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer's Disease

PET Imaging Agent Receives Marketing Authorisation from the European Commission


Read More

August 29, 2014
GE CAPITAL PERÇOIT DES TENDANCES POSITIVES AU NIVEAU DES INDUSTRIES RÉCRÉATIVES CANADIENNES.

Les secteurs sports motorisés et véhicules récréatifs connaissent un bel essor alors que les détaillants de produits nautiques se concentrent sur la gestion de leurs stocks


Read More

August 29, 2014
GE Capital Sees Positive Trends in Canadian Recreational Industries

Motorsports & RV surge ahead while marine dealers focus on managing inventory


Read More